Welcome to the new pharmaphorum
Our website has served us well over the years, but after five years since the last re-design – during which aesthetic standards have changed and website technology has improved
JP Morgan 2023 – Alexandre LeVert
Editor-in-chief Jonah Comstock caught up with Alexandre LeVert, chairman, CEO, and co-founder of Osivax, on the sidelines of JP Morgan in San Francisco at the beginning of January of this year.&nbs
Sanofi drops BTK drug tolebrutinib in myasthenia gravis
Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular diso
Will clinical trials be held in the metaverse? Five ways the...
The pronounced success of increased tech adoption in accelerating and streamlining clinical trials over the past few years has opened the floodgates for a slew of new technology and tactics
Mounjaro misses for Lilly in Q4, but big surge expected
After referring to the launch of its type 2 diabetes therapy Mounjaro as viral e
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
2nd Next Generation Kinase Inhibitors Summit
Industry-dedicated summit focused on advancing the best-in-class kinase inhibitor products
5th Cell Engager Summit
The 5th Annual Cell Engager Summit is back in Boston, MA this year
2nd Next Generation RNA Therapeutics Summit
Bringing Next Generation RNA Therapies to Patients Fast
PharmStars Announces "Women's Health" or "Health Equity" The...
PharmStars Accelerator Open for Applications
Ensuring A Zero-Risk Data Privacy Environment When Capturing...
Capturing Medical Insights With Zero-Risk